A “pharma-ready” fulfillment operation isn’t defined by a single certification or a fancy warehouse label—it’s defined by repeatable workflows that protect product integrity and data integrity. In practice, that means every step from inbound receiving to outbound shipping is designed to prevent mix-ups, control temperature exposure, maintain traceability, including lot, expiry, and serialization where applicable, and produce the documentation you’ll need when questions come up.
Whether you’re distributing temperature-sensitive products, including peptides, clinical supplies, or commercial pharmaceuticals, the operational backbone tends to be the same. The difference between an average 3PL setup and a pharma-ready one is how deliberately these workflows are built, trained, audited, and improved.
Below is a practical blueprint for designing or evaluating a pharma-ready fulfillment operation across four core workflows: receiving, quarantine and release, lot and expiry control, and returns.
If your program includes temperature-sensitive products like peptides, this is also a good companion read to your peptide-specific requirements and handling expectations:
Peptide cold-chain warehousing and fulfillment.
Receiving: Build the “First Line of Defense” Against Errors
Inbound receiving is where many downstream problems begin: wrong item, wrong lot, damaged shipper, incomplete paperwork, or temperature exposure that isn’t documented. A pharma-ready operation designs receiving as a controlled process—not a quick count-and-shelve.
A. Appointment and Pre-Receipt Requirements
Before freight arrives, define what “good inbound” looks like:
- Pre-advise or ASN, also known as advanced shipping notice, with SKU, quantity, lot, expiry, and temperature requirements
- Required documents, such as CoA or CoC as applicable, packing list, temperature data if shipped cold, SDS if needed, and import documents if applicable
- Receiving appointment windows that align with staffing and cold storage availability
B. Physical Receiving Controls: Dock to Staging
Key principles include:
- Segregated receiving area with clear separation from outbound and returns
- Time limits for ambient exposure, especially for 2–8°C or frozen products
- Defined maximum door-to-fridge or door-to-freezer time
- Immediate exception flagging for visible damage, wet cartons, broken seals, missing labels, wrong address, and similar issues
For cold-chain products, a best practice is a documented cold chain receiving path:
- Receive the shipment.
- Inspect the outer shipper quickly.
- Move the shipment to controlled staging or a cold room.
- Complete the detailed check in a temperature-appropriate area.
C. Verification: What to Check Every Time
At minimum, the receiving process should verify:
- SKU or item ID match against the PO or ASN
- Quantity, including units and cases
- Lot or batch and expiry match
- Label condition, including legible and scannable barcodes
- Packaging integrity, including tamper evidence where used
- Temperature indicators or data logger presence if expected
Documented discrepancies should trigger an inbound deviation record. Even for RUO programs, a structured log helps prevent recurring issues.
Quarantine and Release: “Nothing Ships Until It’s Allowed to Ship”
Quarantine isn’t just a physical location—it’s a system of controls that ensures inventory cannot be accidentally allocated or shipped before it’s approved.
A. Quarantine States: Physical and System Controls
Design quarantine with two layers:
- Physical segregation, such as a marked quarantine cage, rack, or room separate from available inventory
- WMS status control, such as a “Quarantine” or “Hold” status that blocks allocation, picking, and shipping
If either layer is missing, the process is fragile. A pharma-ready operation uses both.
B. Define Release Criteria
Release criteria will vary by client and program, but should be clearly defined. Common release requirements include:
- Documentation review complete, including packing list, CoA, and other required documents
- QA release for GMP programs
- Temperature review complete if the product was shipped cold
- Labeling and identification verified
- Any required sampling completed, if applicable
It is common to include two-person verification for release, especially for high-value or regulated SKUs.
C. Handling Exceptions in Quarantine
Common quarantine exceptions include:
- Missing CoA
- Temperature logger showing a potential excursion
- Short shipment or overage
- Damaged cartons
- Lot or expiry mismatch
Each exception should have a defined path:
- Place the inventory on quarantine hold.
- Notify the appropriate stakeholder or stakeholders.
- Decide disposition, such as release, rework, return-to-vendor, or destroy.
- Document the final decision and retain supporting evidence.
This is where good fulfillment operations prove their value: they don’t just pause shipments—they manage the exception cleanly, quickly, and with documentation.
Lot and Expiry Control: Traceability Is the Core of Pharma Fulfillment
Lot and expiry control is not optional in pharma-ready fulfillment. It is the mechanism that protects patients and protects your organization when a recall or investigation occurs.
A. System Requirements for the WMS
At a minimum, the WMS should support:
- Lot number capture at receiving
- Expiry date capture
- Lot and expiry visibility during picking
- Allocation rules, including FEFO, FIFO, and lot restrictions by customer or channel
- Traceability reports showing what shipped, when, to whom, and from which lot
If you handle products like peptides that may have stability constraints or multiple storage temperatures, you also want:
- Storage condition by SKU or lot
- Temperature zone inventory controls
- Reason codes for inventory adjustments
B. FEFO vs. FIFO and Why It Matters
FIFO, or first in, first out, is time-based and can fail if newer inventory expires sooner. FEFO, or first expired, first out, is expiry-based and is typically more appropriate for pharma.
Define FEFO rules carefully:
- Do you allow shipping within a certain number of months of expiry?
- Do you block allocations below a minimum remaining shelf life per customer?
- Are there different thresholds for wholesale, DTC, or clinical sites?
C. Pick and Pack Verification: Reduce “Wrong Lot Shipped”
A pharma-ready design uses layered accuracy controls:
- Scan-based picking, including scan location, scan SKU, and scan lot
- Pack verification, such as weight checks, scan checks, and photo capture if needed
- Shipping label verification to confirm the right carrier, service, and lane for temperature control
Wrong-lot shipments are costly because they create downstream uncertainty and sometimes require a formal investigation. Preventing them is cheaper than fixing them.
Returns Workflow: Treat Returns as a Controlled Quality Process, Not Reverse Shipping
Returns in pharma are complicated because the question isn’t “can we resell it?”—it’s “can we prove it remained within specification and control?”
A pharma-ready returns workflow is designed to:
- Prevent contaminated inventory from re-entering stock
- Maintain chain-of-custody documentation
- Support disposition decisions with evidence
A. Returns Authorization and Triage
Start before the shipment comes back:
- Require an RMA with reason codes, such as damaged, refused, wrong item, temperature concern, and similar categories
- Define return eligibility windows
- Define what must be included, such as photos, temperature logger, and shipper condition notes
When returns arrive:
- Route them directly to returns quarantine, separate from inbound new inventory quarantine
- Record condition on arrival, including photos, seals, and temperature indicators
B. Disposition Paths
Common disposition paths include:
- Restock, which is rare in strict programs and requires evidence and policy approval
- Quarantine for QA review
- Return to vendor or manufacturer
- Destruction, with certificates of destruction where required
- Investigation, if there is a suspected excursion or tampering
The key is that disposition is policy-driven, not ad hoc. Decide in advance what evidence is required to restock, if restocking is allowed at all.
C. Temperature-Sensitive Returns
For cold-chain products, treat returns as high-risk unless you can document:
- How long the product was in transit back
- Whether it was kept within range
- Whether packaging remained intact
- Whether it was out of controlled custody
Many programs default to “do not restock” for cold-chain returns unless strict criteria are met.
The Connective Tissue: SOPs, Training, and Auditability
Even well-designed workflows fail without operational discipline.
A. SOPs and Work Instructions
You’ll want:
- SOPs for receiving, quarantine and release, picking, packing, shipping, and returns
- Deviation or exception SOP defining what qualifies, who approves, and timelines
- Temperature excursion handling SOP for cold chain
- Label control procedures to prevent mislabeling
B. Training and Accountability
Pharma-ready means:
- Role-based training for receiving, picking, QA review, and other functions
- Refresher training cadence
- Error-proofing through scanners, system blocks, and dual verification for key steps
C. Audit Trail and Reporting
Make sure you can produce:
- Receiving logs with lot and expiry
- Quarantine and release timestamps and approvals
- Shipment history by lot for traceability
- Returns logs and disposition evidence
- Deviation trends showing what keeps going wrong and what changed
Practical Checklist: “Is This Fulfillment Operation Pharma-Ready?”
If you’re evaluating your own operation or a 3PL, here’s a quick scorecard:
- Inventory can’t ship unless it’s system-released with true quarantine controls
- Lot and expiry are captured and enforced with scan-based workflows
- FEFO rules and minimum shelf-life thresholds are configurable
- Cold-chain receiving minimizes ambient exposure and documents exceptions
- Returns are routed to returns quarantine, not mixed into regular receiving
- Exceptions trigger documented decisions and consistent dispositions
- Reporting supports traceability, recalls, and customer or QA questions quickly
Jamie Moriarty is an experienced entrepreneur that has founded companies in consumer packaged goods, (Uber Dispensing Co.) technology, (Pauwow) and brokerage and consulting (R.F.Queue).